Vitrolife AB (publ)

OM:VITR Lagerbericht

Marktkapitalisierung: kr23.4b

Vitrolife Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Vitrolife wird ein jährliches Gewinn- und Umsatzwachstum von 105.6% bzw. 7.1% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 105.6% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 5% betragen.

Wichtige Informationen

105.6%

Wachstumsrate der Gewinne

105.6%

EPS-Wachstumsrate

Biotechs Gewinnwachstum40.0%
Wachstumsrate der Einnahmen7.1%
Zukünftige Eigenkapitalrendite5.0%
Analystenabdeckung

Low

Zuletzt aktualisiert10 Jun 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Vitrolife AB (publ) Just Missed Earnings; Here's What Analysts Are Forecasting Now

Feb 05
Vitrolife AB (publ) Just Missed Earnings; Here's What Analysts Are Forecasting Now

Recent updates

Vitrolife (STO:VITR) Is Carrying A Fair Bit Of Debt

Apr 03
Vitrolife (STO:VITR) Is Carrying A Fair Bit Of Debt

A Look At The Fair Value Of Vitrolife AB (publ) (STO:VITR)

Mar 07
A Look At The Fair Value Of Vitrolife AB (publ) (STO:VITR)

Vitrolife AB (publ) Just Missed Earnings; Here's What Analysts Are Forecasting Now

Feb 05
Vitrolife AB (publ) Just Missed Earnings; Here's What Analysts Are Forecasting Now

Vitrolife AB (publ)'s (STO:VITR) Share Price Matching Investor Opinion

Jan 05
Vitrolife AB (publ)'s (STO:VITR) Share Price Matching Investor Opinion

Here's Why We Think Vitrolife (STO:VITR) Is Well Worth Watching

Dec 15
Here's Why We Think Vitrolife (STO:VITR) Is Well Worth Watching

Calculating The Intrinsic Value Of Vitrolife AB (publ) (STO:VITR)

Nov 27
Calculating The Intrinsic Value Of Vitrolife AB (publ) (STO:VITR)

Is Vitrolife (STO:VITR) A Risky Investment?

Nov 06
Is Vitrolife (STO:VITR) A Risky Investment?

An Intrinsic Calculation For Vitrolife AB (publ) (STO:VITR) Suggests It's 27% Undervalued

Aug 25
An Intrinsic Calculation For Vitrolife AB (publ) (STO:VITR) Suggests It's 27% Undervalued

Vitrolife (STO:VITR) Could Easily Take On More Debt

Aug 03
Vitrolife (STO:VITR) Could Easily Take On More Debt

Are Vitrolife AB (publ) (STO:VITR) Investors Paying Above The Intrinsic Value?

May 26
Are Vitrolife AB (publ) (STO:VITR) Investors Paying Above The Intrinsic Value?

Is Vitrolife (STO:VITR) A Risky Investment?

Jan 23
Is Vitrolife (STO:VITR) A Risky Investment?

Vitrolife (STO:VITR) Seems To Use Debt Quite Sensibly

Oct 18
Vitrolife (STO:VITR) Seems To Use Debt Quite Sensibly

Calculating The Fair Value Of Vitrolife AB (publ) (STO:VITR)

Sep 09
Calculating The Fair Value Of Vitrolife AB (publ) (STO:VITR)

Is Vitrolife (STO:VITR) A Risky Investment?

Jul 07
Is Vitrolife (STO:VITR) A Risky Investment?

A Look At The Fair Value Of Vitrolife AB (publ) (STO:VITR)

May 26
A Look At The Fair Value Of Vitrolife AB (publ) (STO:VITR)

Vitrolife (STO:VITR) Seems To Use Debt Rather Sparingly

Mar 31
Vitrolife (STO:VITR) Seems To Use Debt Rather Sparingly

Estimating The Fair Value Of Vitrolife AB (publ) (STO:VITR)

Feb 07
Estimating The Fair Value Of Vitrolife AB (publ) (STO:VITR)

There May Be Reason For Hope In Vitrolife's (STO:VITR) Disappointing Earnings

Apr 29
There May Be Reason For Hope In Vitrolife's (STO:VITR) Disappointing Earnings

Is Vitrolife AB (publ)'s (STO:VITR) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Mar 16
Is Vitrolife AB (publ)'s (STO:VITR) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Who Has Been Selling Vitrolife AB (publ) (STO:VITR) Shares?

Jan 22
Who Has Been Selling Vitrolife AB (publ) (STO:VITR) Shares?

Vitrolife (STO:VITR) Shareholders Have Enjoyed An Impressive 289% Share Price Gain

Dec 18
Vitrolife (STO:VITR) Shareholders Have Enjoyed An Impressive 289% Share Price Gain

Gewinn- und Umsatzwachstumsprognosen

OM:VITR - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (SEK Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/20264,2157319701,1143
12/31/20253,9706748741,0084
12/31/20243,6485697879114
3/31/20243,499-3,836655795N/A
12/31/20233,512-3,851638757N/A
9/30/20233,462402650752N/A
6/30/20233,412388652738N/A
3/31/20233,336412631706N/A
12/31/20223,234394549636N/A
9/30/20222,893353366470N/A
6/30/20222,501349288377N/A
3/31/20222,054305249331N/A
12/31/20211,681341321384N/A
9/30/20211,549415525555N/A
6/30/20211,464399515545N/A
3/31/20211,291325455479N/A
12/31/20201,246287336356N/A
9/30/20201,273276278303N/A
6/30/20201,331294332361N/A
3/31/20201,502377315399N/A
12/31/20191,480383326413N/A
9/30/20191,391371210412N/A
6/30/20191,29733993344N/A
3/31/20191,199324199341N/A
12/31/20181,151310169349N/A
9/30/20181,102294286343N/A
6/30/20181,064284337341N/A
3/31/20181,066276266321N/A
12/31/20171,046264N/A312N/A
9/30/20171,026255N/A281N/A
6/30/2017991234N/A243N/A
3/31/2017913211N/A204N/A
12/31/2016856190N/A181N/A
9/30/2016804188N/A197N/A
6/30/2016771196N/A210N/A
3/31/2016747186N/A196N/A
12/31/2015722183N/A194N/A
9/30/2015660154N/A138N/A
6/30/2015609137N/A132N/A
3/31/2015554122N/A130N/A
12/31/2014511109N/A146N/A
9/30/201449796N/A145N/A
6/30/201448177N/A121N/A
3/31/201446767N/A111N/A
12/31/201345356N/A106N/A
9/30/201342741N/A88N/A
6/30/201340132N/A64N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: VITR wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als schnelleres Wachstum als die Sparquote angesehen wird (1%).

Ertrag vs. Markt: VITR wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als überdurchschnittliches Marktwachstum angesehen wird.

Hohe Wachstumserträge: VITR wird voraussichtlich in den nächsten 3 Jahren rentabel werden.

Einnahmen vs. Markt: VITRDie Einnahmen des Unternehmens (7.1% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Swedish (1.9% pro Jahr).

Hohe Wachstumseinnahmen: VITRDie Einnahmen des Unternehmens (7.1% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: VITRDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (5 %).

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y